Recently, two back‐to‐back studies were disseminated in Cancer Discovery, uncovering that the genetic ablation of SUV39H1 epigenetically augmented chimeric antigen receptor‐T (CAR‐T) cell function against solid tumors.1, 2. Here, SUV39H1 is linked to cancer.